OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adjuvant therapy for stage II melanoma: the need for further studies
Rebecca Lee, Mario Mandalà, Georgina V. Long, et al.
European Journal of Cancer (2023) Vol. 189, pp. 112914-112914
Open Access | Times Cited: 12
Rebecca Lee, Mario Mandalà, Georgina V. Long, et al.
European Journal of Cancer (2023) Vol. 189, pp. 112914-112914
Open Access | Times Cited: 12
Showing 12 citing articles:
Association of HLA-A*02:01 type with efficacy and toxicity of immune checkpoint inhibitor therapy in melanoma patients: a retrospective cohort study
Isabel Manger, Cynthia L. Schmitt, Carola Berking, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Isabel Manger, Cynthia L. Schmitt, Carola Berking, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Predictive Models of Melanoma Metastasis Based on Dermatoscopy: An International Human Reader Study
Konstantinos Lallas, Harald Kittler, Philipp Tschandl, et al.
(2025)
Closed Access
Konstantinos Lallas, Harald Kittler, Philipp Tschandl, et al.
(2025)
Closed Access
Traitements adjuvants et néoadjuvants du mélanome
Joséphine Cazals de Fabel, C. Gaudy‐Marqueste
Bulletin du Cancer (2025)
Open Access
Joséphine Cazals de Fabel, C. Gaudy‐Marqueste
Bulletin du Cancer (2025)
Open Access
Predictive Factors for Sentinel Lymph Node Positivity in Melanoma Patients—The Role of Liquid Biopsy, MicroRNA and Gene Expression Profile Panels
Federico Venturi, Elisabetta Magnaterra, Biagio Scotti, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1281-1281
Open Access
Federico Venturi, Elisabetta Magnaterra, Biagio Scotti, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1281-1281
Open Access
Determining the optimal use of approved drugs in oncology
Gauthier Bouche, Duncan C. Gilbert, Matteo Quartagno, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 5, pp. e282-e294
Closed Access
Gauthier Bouche, Duncan C. Gilbert, Matteo Quartagno, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 5, pp. e282-e294
Closed Access
Melanoma skin cancer
Ana Carolina Cerqueira Mota Benevides, Fernando Nunes Galvão de Oliveira, Carlos Frederico Lopes Benevides
Elsevier eBooks (2025), pp. 575-593
Closed Access
Ana Carolina Cerqueira Mota Benevides, Fernando Nunes Galvão de Oliveira, Carlos Frederico Lopes Benevides
Elsevier eBooks (2025), pp. 575-593
Closed Access
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma
Edoardo De Simoni, Francesco Spagnolo, Sara Gandini, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102788-102788
Closed Access | Times Cited: 2
Edoardo De Simoni, Francesco Spagnolo, Sara Gandini, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102788-102788
Closed Access | Times Cited: 2
An artificial intelligence-based model exploiting H&E images to predict recurrence in negative sentinel lymph-node melanoma patients
Maria Colomba Comes, Livia Fucci, Sabino Strippoli, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Maria Colomba Comes, Livia Fucci, Sabino Strippoli, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Adjuvant PD-1 Checkpoint Inhibition in Early Cutaneous Melanoma: Immunological Mode of Action and the Role of Ultraviolet Radiation
Matthias Brandlmaier, Magdalena Hoellwerth, Peter Koelblinger, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1461-1461
Open Access | Times Cited: 1
Matthias Brandlmaier, Magdalena Hoellwerth, Peter Koelblinger, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1461-1461
Open Access | Times Cited: 1
Ecto-NOX Disulfide-Thiol Exchanger 2 (ENOX2/tNOX) Is a Potential Prognostic Marker in Primary Malignant Melanoma and May Serve as a Therapeutic Target
Matti Böcker, Eftychia Chatziioannou, Heike Niessner, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11853-11853
Open Access | Times Cited: 1
Matti Böcker, Eftychia Chatziioannou, Heike Niessner, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11853-11853
Open Access | Times Cited: 1
Downregulation of MHC-I on melanoma cells and decreased CD8+ T-cell infiltration are associated with metastatic spread and resistance to immunotherapy
Miriam Mengoni, Felix Oliver Mahlo, Evelyn Gaffal, et al.
Laboratory Investigation (2024), pp. 102209-102209
Open Access
Miriam Mengoni, Felix Oliver Mahlo, Evelyn Gaffal, et al.
Laboratory Investigation (2024), pp. 102209-102209
Open Access
Adjuvant or neoadjuvant treatment with immune checkpoint inhibitors: re-assessing the risk–benefit ratio
Julie Delyon, Olivier Michielin
The Lancet Oncology (2023) Vol. 25, Iss. 1, pp. 3-5
Closed Access | Times Cited: 1
Julie Delyon, Olivier Michielin
The Lancet Oncology (2023) Vol. 25, Iss. 1, pp. 3-5
Closed Access | Times Cited: 1
Annals of Surgical Oncology Practice Guidelines Series: Adjuvant and Neoadjuvant Therapy for Melanoma
Jeffrey M. Farma, Anthony J. Olszanski, Jane L. Messina, et al.
Annals of Surgical Oncology (2024)
Open Access
Jeffrey M. Farma, Anthony J. Olszanski, Jane L. Messina, et al.
Annals of Surgical Oncology (2024)
Open Access
Patterns of systemic treatment for melanoma: an insight on trends and costs between 2019–2023 from the English systemic anti-cancer therapy national database
Tommaso Bosetti, Oliver John Kennedy, Rebecca Lee, et al.
EJC Skin Cancer (2024), pp. 100279-100279
Open Access
Tommaso Bosetti, Oliver John Kennedy, Rebecca Lee, et al.
EJC Skin Cancer (2024), pp. 100279-100279
Open Access
